These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 4945137)

  • 1. [Clinical usefulness of detection of serum antinuclear antibodies by the immunofluorescence method].
    Wranicz A
    Przegl Dermatol; 1971; 58(6):685-90. PubMed ID: 4945137
    [No Abstract]   [Full Text] [Related]  

  • 2. The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence.
    Burnham TK; Neblett TR; Fine G; Bank P
    Arch Dermatol; 1969 May; 99(5):611-6. PubMed ID: 4889089
    [No Abstract]   [Full Text] [Related]  

  • 3. [Possibilities of differentiation of antinuclear antibodies].
    Müller W; Rosenthal M; Stojan B
    Z Gesamte Inn Med; 1975 Oct; 30(20):665-71. PubMed ID: 766433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinucleolar antibodies. Their frequency and diagnostic association.
    Ritchie RF
    N Engl J Med; 1970 May; 282(21):1174-8. PubMed ID: 4909324
    [No Abstract]   [Full Text] [Related]  

  • 5. [Early detection and early differentiation of collagenoses--a task for the clinician].
    Herzer P
    Verh Dtsch Ges Inn Med; 1986; 92():53-61. PubMed ID: 3492831
    [No Abstract]   [Full Text] [Related]  

  • 6. [Demonstration of antinuclear factors using indirect immunofluorescence in scleroderma patients].
    Nebe H; Blume N
    Dermatol Monatsschr; 1971 Jan; 157(1):27-31. PubMed ID: 4938251
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance and diagnostic value of different types of antinuclear antibodies demonstrated by immunofluorescence on smears of trypanosomed mice blood].
    Monier JC; Thivolet J; Sepetjian M; Beyvin AJ; Pousset G
    Lyon Med; 1970 May; 223(20):1007-18. PubMed ID: 4913277
    [No Abstract]   [Full Text] [Related]  

  • 8. [An immunofluorescence method for detection of anti-DNA-antibodies (author's transl)].
    Helmke K; Wölke U; Federlin K
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):162-71. PubMed ID: 4283272
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current immunological diagnosis of collagenoses. I. Systemic lupus erythematosus and systemic scleroderma].
    Jarzabek-Chorzelska M; Kołacińska-Strasz Z; Błaszczyk M; Chorzelski T; Jabłońska S
    Przegl Dermatol; 1987; 74(6):421-30. PubMed ID: 3330246
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of indirect immunofluorescence test by Weller and Coons for demonstration of antinuclear factors].
    Nebe H
    Dermatol Monatsschr; 1970 Oct; 156(10):913-8. PubMed ID: 4927926
    [No Abstract]   [Full Text] [Related]  

  • 11. A.N.A.
    Schur PH
    N Engl J Med; 1970 May; 282(21):1205-6. PubMed ID: 4909326
    [No Abstract]   [Full Text] [Related]  

  • 12. The diagnostic value of an antinuclear antibody test in clinical dermatology.
    Rowell NR; Beck JS
    Arch Dermatol; 1967 Sep; 96(3):290-5. PubMed ID: 5341548
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O; Haïm T
    Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinuclear antibodies in dermatology.
    Heffernan MP; Do JH; Mehta J
    Semin Cutan Med Surg; 2001 Mar; 20(1):2-13. PubMed ID: 11308133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Crithidia luciliae and Farr assays for the detection of systemic lupus erythematosus.
    Burdash NM; Teti G; Papadopoulos V
    Ann Clin Lab Sci; 1983; 13(1):49-54. PubMed ID: 6340594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunofluorescent studies in some autoimmune syndromes. I. Lupus erythematosus].
    Chorzelski T; Blaszczyk M
    Przegl Dermatol; 1971; 58(4):485-8. PubMed ID: 4938588
    [No Abstract]   [Full Text] [Related]  

  • 17. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
    Peltier AP
    Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunologic tests: Anti Ki/PA28gamma antibody].
    Okano T; Satoh M; Akizuki M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():519-22. PubMed ID: 16111319
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunofluorescent technic to detect antinuclear factors].
    Cossio PM; Arana R; Garcia Morteo O
    Prensa Med Argent; 1968 Aug; 55(27):1302-6. PubMed ID: 4883211
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative evaluation of antinuclear factor tests in rheumatic disorders.
    Willkens RF; Decker JL; Wilske KR
    Med Clin North Am; 1968 May; 52(3):559-65. PubMed ID: 4385202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.